Denmark s approval of novel COVID-19 treatment by the US pharmaceutical company Merck has run into difficulties as the country s GPs refuse to prescribe the treatment due to insufficient knowledge of how it works.
The National Board of Health in Denmark has approved the use of US drugmaker Merck’s anti-COVID-19 pill that goes under the name molnupiravir or Lagevrio.